Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Kidney Disease

Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems http://www.drug-injury.com/druginjurycom/2009/11/aranesp-darbepoetin-alfa-associated-with-heightened-stroke-risk-amgen-treat-study-nejm-october.html
Contributor
Wilmington, North Carolina
Personal Injury
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.